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ABSTRACT
Vibrio vulnificus and Vibrio parahaemolyticus are both bacteria that cause human
infection. V. vulnificus has a polysaccharide locus, rbd, responsible for bacterial
aggregation, a form of biofilm. This locus is conserved in V. parahaemolyticus and in the
non-pathogen V. fischeri.
In V. fischeri, the polysaccharide locus, syp, has been extensively characterized
and shown to be important for biofilm formation. In V. fischeri, the first gene, sypA, is
critical for biofilm formation. V. fischeri biofilm-proficient strains form wrinkled
colonies. In contrast, sypA mutants form smooth colonies, indicating a lack of biofilm
formation.
To understand the function of RbdA and SypAVP, proteins encoded by the first
genes in the respective polysaccharide loci, in biofilm formation, we hypothesized we
could use the well-characterized V. fischeri model of biofilm formation. I found that rbdA
and sypAVP are able to promote biofilm formation in V. fischeri. Additionally, RbdA and
SypAVP function appear to be controlled by SypE, the negative regulator of SypA in V.
fischeri.
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CHAPTER ONE
LITERATURE REVIEW

I.

Introduction

Vibrio vulnificus is a halophilic bacterium naturally occurring in marine and estuarine
environments. Vibrio parahaemolyticus is also a halophilic bacterium. It is found
naturally in warm, brackish saltwater in coastal waters around the United States and
Canada. Both bacteria are opportunistic human pathogens that can cause gastrointestinal
and severe wound infections [1]. Many factors allow these bacteria to cause disease in
humans. One likely factor is the ability to form a biofilm. A biofilm may form in the
environment, for example, on an oyster. Biofilms that are not removed from oysters that
are harvested for human consumption may increase the transmission of bacteria to the
human host [2]. A biofilm may also form in the human host, causing persistent infection
[3]. Both bacteria encode genes for the production and transport of a polysaccharide that
may contribute to the formation of the biofilm, but the individual genes of these loci have
not been characterized [4].
Vibrio fischeri is a related, non-pathogenic Vibrio species that is a symbiont of the
Hawaiian bobtail squid, Euprymna scolopes. To efficiently colonize the squid, Vibrio
form a biofilm. Biofilm formation is dependent on an 18-gene locus called syp [5, 6].
1
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Genes involved in forming the biofilm and associated behaviors have been
extensively characterized. The first gene in the syp locus encodes a STAS domain
protein, which is a regulator of biofilm formation. The first genes in the V. vulnificus and
V. parahaemolyticus loci also encode STAS domain proteins. Therefore, V. fischeri
biofilm formation serves as a model for the study of biofilm formation in other related
Vibrio species. Biofilms are of clinical significance and how a model organism forms a
biofilm could provide insight into the pathogenesis of bacteria that form biofilms.

II.

Vibrio vulnificus

Clinical significance
Disease associated
V. vulnificus is an opportunistic pathogen that can cause disease in healthy
individuals in two ways: via ingestion of contaminated food such as raw seafood,
particularly oysters, or via exposure of an open wound to infected seawater. In healthy
individuals, ingestion of V. vulnificus can cause infection with symptoms ranging from
vomiting to diarrhea to abdominal pain. The initial gastrointestinal infection can become
systemic, causing a serious disease with symptoms including fever, chills, decreased
blood pressure, and culminating in septic shock. Infection can also cause a blistering
dermatitis. Systemic infection is more likely to occur in immunocompromised individuals
than healthy patients. V. vulnificus can also cause infection when bacteria living in
seawater come into contact with an open wound. In the wound route of infection, disease
can lead to skin breakdown and ulceration. Systemic infection stemming from a wound

infection can result in complications with symptoms similar to the systemic
gastrointestinal infection [1].
Immunocompromised individuals are susceptible to a variety of infections that
normally pose little risk to healthy individuals. Certain medical conditions, such as liver
dysfunction and other syndromes that lead to increased iron deposition, including as
chronic cirrhosis, hepatitis, thalassemia major, hemochromatosis, and heavy alcohol
consumption, predispose individuals to infection by V. vulnificus through either route of
infection, ingestion or contact [7]. In immunocompromised individuals with V. vulnificusinfected wounds, there is a higher risk for bloodstream invasion, and individuals can
suffer from serious complications, including potentially death. Infections that become
systemic can have a mortality rate as high as 50%. [1].
Incidence
V. vulnificus is an underreported cause of disease, in part because reporting is
only required in a subset of states in the U.S.. Most cases occur in the Gulf Coast. The
Center for Disease Control reports there were more than 900 cases between 1998 and
2006 in the Gulf Coast [1]. The number of infections in this time period increased 78%.
There are an average of 50 culture-confirmed cases per year. On average, there are 45
hospitalizations and 16 deaths reported per year just from the Gulf Coast, which includes
the states of Alabama, Florida, Louisiana, Mississippi, and Texas. For the nation, there
are approximately 95 cases reported per year; however, only half of those cases are
culture-confirmed. Nationwide, there are 85 hospitalizations and 35 deaths [1].
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V. vulnificus infections and outbreaks occur worldwide. In Japan, there is an
estimated occurrence of 425 cases of V. vulnificus per year, although the infection is not
reportable in that country [8]. Japan’s warm coastal waters make it an ideal environment
for the growth of V. vulnificus. Japan also has a higher rate of raw seafood consumption
increasing the likelihood of potential infection [9].
Pathogenesis
Those with pre-existing medical conditions, including those with chronic liver
disease, are 80 times more likely to develop bloodstream infections [1]. Septicemic
infections occur upon bacterial invasion of the intestinal mucosa. From the intestinal
mucosa, bacteria can enter the bloodstream [7]. There are two hallmarks of V. vulnificus
disease: extreme destruction of host tissues and rapid proliferation of the bacteria. While
virulence factors associated with the bacteria have been identified, little is known about
what directly contributes to the hallmarks of disease [10].
Virulence factors
The most important virulence factor for V. vulnificus is the production of capsular
polysaccharide (CPS), which protects the bacteria from host responses such as
complement and phagocytosis by host immune cells [10]. V. vulnificus strains that do not
form a capsule are attenuated in mouse models. These strains are also susceptible to
human serum that contains bactericidal activity. Unfortunately, the antigenicity of the
capsule can vary among different strains, making the capsule a poor vaccine target [9].
The ability to acquire iron from the environment is considered another important
virulence factor of V. vulnificus. There is increased infection susceptibility and disease
4

severity in hosts with increased iron levels. To cause severe infection, the bacterium
relies on iron imbalance or on factors than cause an iron imbalance [11]. Work in the role
of iron in V. vulnificus is ongoing, but evidence suggests that iron manipulation by the
bacteria can have two effects. One effect is that high iron levels can inhibit host
responses, such as inhibiting neutrophil function. High iron can also significantly
increase bacterial replication in skin tissue [12]. How either of these mechanisms occurs
has yet to be elucidated.
V. vulnificus uses a flagellum for motility. Mutants defective flagellar components
have been assessed for virulence and a range of defects have been observed. One such
mutation in the flagellar gene flgC resulted in a strain that was attenuated when orally
inoculated in mice. Attenuation could be a result of decreased motility or a result of
decreased adherence. flgC mutant strains also have decreased adherence to cells [13].
Another flagellar mutant, fliP, was also non-motile and attenuated in mice. This mutant
was able to cause severe skin infection but not systemic infection [9]. The difference
between the two mutants and their ability to cause infection suggests that there may be
other factors that contribute to the pathogenicity of the organism.
Other virulence factors of V. vulnificus include hemolysins, cytolysins, and
metalloproteases [9]. When these secreted proteins are purified and injected into animals,
some of the pathology of infection can be replicated. Injection of purified hemolysin
causes skin damage by forming pores in host cell membranes. The formation of pores can
lead to vasodilation and edema in blood vessels, symptoms that resembles those that
occur during infection. When a purified metalloprotease was injected into mice, it caused
5

dermal necrosis, increased vascular permeability, and edema. However, when the gene
for either the metalloprotease or a hemolysin or cytolysin was mutated in V. vulnificus,
the mutant showed little attenuation in an animal model [9].
Other putative virulence factors have been identified, including the RtxA toxin
and pili. The RtxA toxin causes depolymerization of actin in HeLa cells in a contactmediated manner. The toxin causes pore formation in red blood cells and necrosis in
hepatic cells. In a mouse model, however, an rtxA mutant was not attenuated. The
presence of pili is associated with epithelial cell adherence. Pili mutants no longer
produce pili or, surprisingly, hemolysin or cytolysin. Chitinase secretion is also inhibited
in pili mutants. This mutant was attenuated in mice but the reason for attenuation may be
due to the lack of hemolysin or cytolysin or chitinase secretion [9].
Economic and environmental burden
One of the primary vectors of infection with V. vulnificus is the oyster. Oysters
can only be legally harvested from waters free from fecal contamination. However, V.
vulnificus can be present in non-fecal contaminated waters as it is a natural inhabitant of
marine environments. The presence of the bacteria does not alter the appearance, taste, or
odor of the oysters. Infections are reported to the Food and Drug Administration, which
identifies the source of infection, preventing further infection in humans. These efforts
can help predict environmental factors that increase the chance that oysters carry
pathogens [1]. The increase in reported infections could be due to climate change
resulting in increased marine temperatures. While there have been more cases of
infection, the rate of infection has not increased [14].
6

Studies determining differences between clinical and environmental isolated
strains are ongoing. Studies have found that oyster isolates have the ability to cause
disease in mice, although clinically isolated strains had a higher prevalence of causing
systemic infection in mice. In the clinic however, wound infections do not always
progress to systemic disease. These results suggest that there is a difference between
strains that cause systemic infection and those that cause wound and gastrointestinal
infections only. Thus, there appear to be different populations of V. vulnificus, a
population that can cause destruction and localized infection and a population that causes
systemic infection. The factors that distinguish the two bacterial populations have yet to
be identified [9]. The differences in host populations that become infected with either
wound infections or gastrointestinal infections have yet to be identified as well.

III.

Vibrio parahaemolyticus

Clinical significance
Disease associated
V. parahaemolyticus can cause disease in humans who ingest seafood, including
raw or undercooked shellfish particularly oysters, contaminated with the bacteria.
Symptoms of the illness caused by V. parahaemolyticus include abdominal cramping,
nausea, vomiting, fever, and chills. Symptoms usually occur 24 hours after ingestion of
contaminated food. Infection is self-limiting lasting on average three days.
Immunocompromised individuals and those with weakened immune systems can have
more severe and prolonged illnesses. Medical conditions including alcoholism and liver
7

disease may increase the risk of severe and prolonged disease. Wound infections can also
occur when an open wound is exposed to infected warm seawater; however, this route of
infection is less common. Infection rarely spreads to the bloodstream [15].
Incidence
V. parahaemolyticus was first discovered after a food poisoning outbreak in Japan
in 1950. The outbreak affected 272 individuals making V. parahaemolyticus one of the
leading causes of foodborne illnesses [16]. In Asian countries such as Taiwan and Japan,
consumption of raw seafood is not uncommon leading to higher rates of infection [2].
In 1971, the United States had its first V. parahaemolyticus outbreak in Maryland
after individuals consumed infected crabmeat [17]. The CDC estimates that there are
4500 cases of V. parahaemolyticus infection each year. The number of cases is
underreported as the disease is self-limiting, preventing many people from seeking
medical attention. Additionally, laboratories rarely use the selective media required to
identify V. parahaemolyticus. There are approximately 215 culture-confirmed cases, 30
hospitalizations, and 1-2 deaths reported each year to the CDC [15].
Pathogenesis
V. parahaemolyticus causes infection by invading the intestinal epithelia of
humans after ingestion of contaminated seafood such as shellfish or oysters [15]. Bacteria
adhere to the intestinal epithelia [18]. The bacteria then inject toxins into the host cells
via a type III secretion system; these toxins can cause a change in the ion flux in the cell,
ultimately leading to cell death. Cell death and alterations in the ion flux of the cell cause
the symptoms that manifest in the clinic [2].
8

Virulence factors
The thermostable direct hemolysin (TDH) is an important virulence factor of V.
parahaemolyticus. This hemolysin is responsible for the beta-hemolysis seen when
bacteria are grown on blood agar plates [19]. TDH is a pore-forming toxin that alters the
ion flux in intestinal cells. This alteration causes diarrhea. Other TDH-related hemolysins
have been identified. These toxin-like proteinaceous substances can cause death in mice
at high concentrations and diarrhea at low concentrations. Both toxins have been isolated
in clinical strains of V. parahaemolyticus that cause gastroenteritis; however, the genes
for these toxins are missing from most environmental isolates [2].
The ability to hydrolyze urea is another important virulence factor of V.
parahaemolyticus. Although the role of urease activity in pathogenicity is unclear, urease
activity has been correlated with the presence of TDH [2]. Like V. vulnificus, an
important virulence factor for V. parahaemolyticus is the ability to acquire iron.
Vibrioferrin is a novel siderophore that may provide bacteria with a competitive
advantage for surviving in an iron-limited environment [20]. It has been previously
shown that strains grown in iron-limiting conditions exhibited greater adherence,
increased hemolysis, and higher rates of proliferation [21, 22].
Investigators hypothesize that bacteria first adhere to host cells and then produce
toxins, thus causing disease. V. parahaemolyticus produces heat-stable somatic O
antigens (lipopolysaccharide), heat-labile capsular K antigens (capsular polysaccharide),
and H antigens (flagellar antigens) [18]. Recent studies have shown that strains grown in
the presence of bile or deoxycholate had increased capsule size and exhibited increased
9

adherence to epithelial cells [18]. The in vitro concentrations of bile and deoxycholate
used in this study are within the physiologic range found in humans, suggesting that the
presence of bile and deoxycholate could have effects on V. parahaemolyticus capsular
size, and therefore adherence, during human infection. In other enteric bacteria, it has
been previously shown that increased capsular size correlates to increased virulence. In V.
parahaemolyticus, the increased capsule and increased adherence could allow the
bacteria to aggregate and adhere to intestinal cells, thus promoting disease [18].
Emerging data suggest that the presence of a type III secretion system within a
pathogenicity island plays a role in V. parahaemolyticus virulence. Type III secretion
systems have been shown in other bacteria to function in the export of bacterial virulence
factors into host cells. Vibrio cholerae is a related pathogenic bacterium that, like V.
parahaemolyticus, causes diarrheal diseases. In V. parahaemolyticus infection, diarrhea is
considered an inflammatory response [2]. In V. cholerae, the response is noninflammatory [23], suggesting there could be two different mechanisms of action causing
diarrhea by Vibrio species. This difference could in part be explained by the presence of a
type III secretion system. V. cholerae does not encode a type III secretion system. It is
hypothesized that the presence of the type III secretion system is important in disease that
results in a non-inflammatory response [2].
Environmental and economic burden
V. parahaemolyticus infections occur seasonally with 70% of infections occurring
between the months of May and October due to warmer water temperatures, which are
optimal for bacterial growth. Large outbreaks have been linked to the consumption of
10

oysters. Environmental factors, such as warm water and moderate salinity, caused an
increase in the number of V. parahaemolyticus organisms in shellfish and thus played a
role in the outbreaks in 1997, 1998, and 2006 [15].
Several techniques are employed to ensure the removal of potentially harmful
bacteria from shellfish populations. Relaying, a technique used to purify oysters, involves
transferring contaminated shellfish from restricted areas to approved natural biological
purification areas. Depuration, another oyster purifying technique, involves the same
process except contaminated shellfish are transferred to a controlled aquatic environment
instead of a natural environment. Several techniques have been employed to decrease
bacterial load post-harvest as the bacteria can rapidly replicate while shellfish are held at
room temperature. Mild heat treatment, low temperature pasteurization, high-pressure
processing, and low dose irradiation can reduce the number of bacteria associated with
oysters. Strains of V. parahaemolyticus have different sensitivities to treatments. Finding
a treatment or combination of treatments that eliminates all strains of V.
parahaemolyticus is ongoing in the oyster industry [2].

IV.

Vibrio fischeri

Symbiotic relationship
Vibrio fischeri is a non-pathogenic Vibrio species. The bacterium is a symbiont of
the Hawaiian bobtail squid, Euprymna scolopes. The bacterium colonizes the light organ
of the juvenile squid. The colonization is highly specific as V. fischeri is the only
colonizer of the squid organ despite the number of the closely related bacteria present in
11

the seawater [24]. One step in early colonization involves the formation of a biofilm on
the surface of the squid’s symbiotic organ, the light organ [6, 25, 26]. Biofilm formation
is required for V. fischeri to efficiently colonize its symbiotic host, and depends on a
cluster of genes called the syp locus, for symbiosis polysaccharide locus [5, 6].

V.

Bacterial Biofilm Formation

Stages of biofilm formation
A biofilm is a complex community of microorganisms that adhere to each other
and, typically, to a surface. Bacteria within the biofilm are embedded in a matrix
consisting of polysaccharides and other molecules such as proteins and DNA. The matrix
can protect commensal and pathogenic bacteria from environmental stresses, such as
antibiotics, as well as from host responses [27, 28]. Other polysaccharides, such as
capsular polysaccharides, produced by bacteria can protect the bacteria from host
responses and allow them to stick to host cells [14].
Biofilms form when free-living bacterial cells respond to environmental cues that
trigger changes in gene expression that allow bacteria to attach to surfaces. The initial
interaction between the bacterial cells themselves and between the cells and a surface
occurs when any of a variety of cell structures ranging from pili to polysaccharides
promote attachment. After attachment, the biofilm matures. This stage is marked by two
properties: increased exopolysaccharide production and increased antibiotic resistance.
During biofilm maturation, bacteria may develop additional properties such as increased
resistance to UV light, increased rates of genetic exchange, increased secondary
12

metabolite production, and altered biodegradative capabilities. The last stage of biofilm
formation involves detachment from the biofilm. In a patient, this detachment can allow
bacteria to disseminate to another site, form a biofilm, and cause persistent disease. The
molecular mechanisms underlying these changes are an active area of research [29].
Clinical relevance of biofilm formation
Biofilms allow bacteria not only to colonize human hosts growing on prosthetic
devices and catheters, causing persistent infection, but also promote their survival.
Bacteria within biofilms pose a threat in the clinical setting because bacteria exhibit a
decreased susceptibility to antimicrobial agents. This could be an intrinsic property of the
bacteria or it could be an acquired property. Transfer of antibiotic resistance genes
between different populations of bacteria within the biofilm could give the bacteria a
survival advantage when faced with antimicrobial agents. Bacteria within a biofilm are
often more resistant to antibiotics than planktonic cells. The differences in antibiotic
susceptibilities between cell types can be problematic in the laboratory setting as
antimicrobial susceptibility testing is done on planktonic cells. The microdilution testing
that is used in the clinical laboratory does not accurately determine the susceptibility of
bacteria within the biofilm [3].
Most bloodstream infections are caused by the release of bacteria from the biofilm
on an indwelling catheters, prosthetics, or other indwelling medical devices. Bloodstream
infections originating from an infection of an indwelling catheter are most often caused
by a biofilm forming on the indwelling medical device. Greater understanding of how
biofilms form on indwelling devices can provide insight on how to treat infections [3].
13

Biofilm formation and aggregation in V. vulnificus
Biofilm formation by bacteria in a human host can have serious consequences in
the clinical setting. The production of polysaccharides plays a large role in biofilm
formation, and phenotypes of biofilm formation can be measured in the lab by the
production of rugose colonies, pellicles, or aggregate formation [4]. V. vulnificus has two
polysaccharide loci that have been studied. One polysaccharide locus, designated rbd for
regulation of biofilm development, is responsible for bacterial aggregation [4]. Wild-type
strains of V. vulnificus are able to form biofilms on glass slides and on the surface of a
crab shell. However, when the rbd locus was disrupted, V. vulnificus strains formed a less
extensive biofilm on either surface suggesting the rbd polysaccharide locus is important
for the formation of the biofilm. In contrast, disruption of the rbd locus did not impact
rugose phenotype, suggesting that the rbd locus is not important for this phenotype.
Indeed, disruption of a second polysaccharide locus, brp (for biofilm and rugose
polysaccharide), which was previously shown to be involved in biofilm formation,
abolished the rugose phenotype [4].
Further studies determined the rbd locus was, instead, important for aggregation.
To evaluate aggregation, researchers grew wild-type stains and rbd-overexpressing
strains overnight, and then allowed the cultures to sit for 5 seconds or 5 minutes. Wildtype stains of V. vulnificus formed little to no ring on the sides of the culture tube, while
the rbd-overexpressing strains produced a biofilm ring on the sides of the culture tube.
Strains overexpressing rbd also formed a visible cell aggregate. The same experiments
tested the ability of brp-overexpressing strains to form aggregates. In combination with
14

the rugose phenotype experiments, it was concluded that rbd has a more dramatic effect
on aggregation, while brp has greater impact on rugosity [4]. These studies suggest that
V. vulnificus can form different biofilms using different polysaccharides.
In other studies, investigators sought to determine the contribution of the rbd
polysaccharide locus to disease in a mouse model. It was found that when mice were
infected with a V. vulnificus strain in which the rbd locus was disrupted, there was no
effect in attenuation in mouse lethality. Although work to date has not revealed a role for
rbd in mouse colonization, it remains possible that this locus may be one of the factors
that contribute to persistence in the oyster population [30]. rbd may be triggered to
enhance colonization of the oyster, or other shellfish, by enabling the dissemination of
aggregates of bacteria that can be easily retained by the filter-feeding host or captured
from the water environment [4].
Conservation and role of polysaccharides in biofilm formation
To produce a biofilm, bacteria secrete an extracellular matrix that holds the
bacterial community together. One component of the extracellular matrix is
polysaccharide [31]. The rbd locus, which encodes genes for the production and transport
of a polysaccharide, in V. vulnificus has been shown to be involved in aggregation. This
polysaccharide locus is conserved in V. parahaemolyticus as well as in the nonpathogenic V. fischeri. When induced to form a biofilm, V. fischeri produces the Syp
polysaccharide, and this biofilm formation in V. fischeri depends on Syp polysaccharide
production [6]. When the syp locus is expressed, V. fischeri produces wrinkled colonies,
pellicles, and extracellular matrix. When any of the syp genes are lost, the wild-type
15

phenotype is restored as no wrinkled colonies are produced, and no extracellular matrix
appears to be present [25].
Additionally, disruption of the syp locus abolishes colonization [6, 25, 26]. The
syp cluster can be over-expressed in vitro to permit the study of biofilm formation [26].
When a regulator of the syp locus is over-expressed, strains of V. fischeri form wrinkled
colonies when spotted on to agar plates and form pellicles in static liquid culture (Figure
1).
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Figure 1. Transcriptional regulation of the syp locus. The histidine kinase RscS acts upstream
of the syp-encoded response regulator SypG to control syp transcription. RscS is activated and
autophosphorylates upon sensing an unidentified signal and serves as a phosphodonor for SypG.
Phosphorylated SypG activates transcription of the individual operons. Transcription of the locus
leads to polysaccharide production, which in turn leads to the formation of wrinkled colonies
when cells are grown on agar plates.
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The first gene in the polysaccharide locus in V. fischeri is sypA, which encodes the
protein SypA, a regulator of biofilm formation. SypA has a sulfate transporter and antisigma factor antagonist (STAS) domain. Although the specific function of SypA is
unknown, this protein is required for biofilm formation by V. fischeri [32, 33]. The
activity of SypA is regulated by another protein encoded by the polysaccharide locus,
SypE. SypE phosphorylates a conserved serine residue, serine 56, within a consensus
sequence of SypA [32].

VI.

STAS Domain Proteins

The first gene encoded in the syp locus is sypA. Interestingly, a STAS domain is
encoded in the first gene of the rbd locus, rbdA, in V. vulnificus and in the first gene of
the V. parahaemolyticus polysaccharide locus, sypAVP. While the individual genes of the
V. vulnificus locus, including rbdA, have not been well characterized [4], there is much
known about the V. fischeri STAS domain protein, SypA. In V. fischeri, the STAS
domain protein, SypA, is a regulator of biofilm formation and is required for
polysaccharide production and biofilm formation [32, 33]. Although its function is
unknown, evidence suggests it functions differently from the best studied STAS domain
proteins.
Characteristics of STAS domain proteins
Sulfate transporter and anti-sigma factor antagonist (STAS) domain proteins that have
been well characterized are typically involved in stress responses in the cell, and the
18

function of STAS domain proteins has been studied in many different bacterial models
[34]. The first studied STAS domain proteins were single domain anti-sigma factor
antagonists. This type of STAS domain protein indirectly activates transcription by
inactivating an inhibitor of transcription such as an anti-sigma factor kinase. The
inactivation of the anti-sigma factor kinase allows sigma factors to activate transcription
[35].
STAS domain proteins have been shown to have a variety of other functions. STAS
domain proteins can also bind nucleotides. Some interact within a multi-domain protein
to sense light, oxygen, or other proteins. STAS domain proteins exhibit a conserved fold
of 4 β sheets interspersed among 5 α helices [35].
Role of STAS domain proteins in non-Vibrio species
i. SpoIIAA
Bacteria encounter a wide variety of stresses. Some stresses are extreme, and in
the presence of extreme stress can cause the bacteria to sporulate, as is the case with
Bacillus subtilis. When B. subtilis is faced with stress, such as starvation, cells begin to
sporulate. B. subtilis sporulation, the small STAS domain protein, SpoIIAA, interacts
with the anti-sigma factor SpoIIAB to promote activation of transcription of σF genes that
lead to sporulation. In this pathway, the anti-sigma factor SpoIIAB binds to σF,
preventing it from binding polymerase. SpoIIAA binds SpoIIAB. This binding between
SpoIIAA and SpoIIAB promote a steric and electrostatic clash that leads to the
dissociation of SpoIIAB from σF, thus permitting activation of sporulation gene
transcription. SpoIIAA is controlled via phosphorylation. When SpoIIAA is
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phosphorylated, it dissociates from SpoIIAB. When SpoIIAA is unphosphorylated, the
protein is able to form a tight complex such that SpoIIAB can no longer bind to σF [35].
It is known that when cells are induced to sporulate, the concentrations of GTP
and GDP significantly decrease. SpoIIAA acts not only as an anti-anti-sigma factor but
also as a GTP-binding protein. It was also found that SpoIIAA has GTPase and ATPase
activity. When the site of phosphorylation is mutated in SpoIIAA, the GTPase activity
was diminished [36].
ii. RsbV
Bacteria also encounter less extreme stresses more frequently. B. subtilis can also
respond to frequent, moderate stresses it encounters by controlling gene expression
through use of an anti-sigma factor, RsbW, and an anti-sigma factor antagonist, RsbV.
When B. subtilis is not stressed, the sigma factor σB is held inactivated in a complex with
the anti-sigma factor kinase RsbW. When the cell encounters stress in the form of
temperature, pH, osmolarity, ethanol, blue light changes or cell wall stress, the anti-anti
sigma factor RsbV can inhibit RsbW [37, 38]. RsbV itself is controlled via
phosphorylation by RsbW, releasing σB to induce stress response genes. This inhibits the
anti-anti-sigma activity of RsbV. It can be further dephosphorylated by RsbU which
restores the anti-anti-sigma activity of RsbV (Figure 2) [35].
In addition to the RsbV STAS domain protein, there are other STAS domain
proteins in this B. subtilis stress response pathway, including RsbR and RsbS. RsbU,
which is one of the regulators of RsbV activity, is controlled by a complex of proteins
that integrates several stress signals to effect a single outcome called the stressosome
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(Figure 2) [35]. The signal transduction cascade increases the expression of genes that
respond to stress [34]. The stressosome consists of 40 copies of the multidomain STAS
protein RsbR, 20 copies of the simple STAS domain protein RsbS, and 20 inactive,
sequestered copies of the switch kinase RsbT [37]. RsbR has a C-terminal STAS domain
and an N-terminal globulin fold domain that has an as of yet unknown function [35].
In response to stress, RsbT phosphorylates RsbR and RsbS, promoting the release
of RsbT from the stressosome. Free RsbT activates RsbU phosphatase. Active RsbU is
then able to remove the inhibitory phosphoryl group from RsbV, permitting RsbV to bind
to RsbW. RsbW releases σB, allowing it to activate RNA polymerase and transcribe the
σB regulon. The stressosome is inactivated by the dephosphorylation of the stressosome
proteins RsbS and RsbR by the phosphatase RsbX. This activation of stress response
genes is highly sensitive with high cooperativity [37, 39].
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Figure 2. The Rsb Stressosome. The stressosome, made up of STAS proteins RbsR and RbsS,
sequesters RsbT. Under stress, RsbT phosphorylates RsbR and RsbS. RsbT is then released and
free to activate RsbU. The RsbT/RsbU complex dephosphorylates RsbV which is then able to
bind the anti-sigma factor RsbW. RsbV binding to RsbW liberates σB from the inactivating
complex with RsbW. Free σB can then bind RNA polymerase to promote gene expression [35].
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iii. Rv1739c
STAS domain proteins also play a role in anion transport. Mycobacterium
tuberculosis has a sulfate or anion transporter that is comprised of a SulP-type
transmembrane domain and a C-terminal cytoplasmic STAS domain, Rv1793c. When
purified, Rv1793c was found to bind guanine nucleotides. It was also found that the
protein had modest GTPase activity. Interestingly, this protein does not serve as a
phosphorylation target [35]. It has been shown that the Rv1793c undergoes
conformational changes when bound to either GTP or GDP. The differences in the
conformation of Rv1793c when bound to either GTP or GDP give more insight into the
interaction between nucleotides and STAS domain proteins [36].
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CHAPTER TWO
MATERIALS AND METHODS

Strains and Media. Bacterial strains used in this study are listed in Table 1. V. fischeri
strains were derived by conjugation. Escherichia coli GT115 (Invivogen, San Diego, CA)
was used for cloning and conjugation experiments [40, 41]. V. fischeri strains were
cultured in Luria-Bertani salt (LBS) [42]. The following antibiotics were added to LBS
medium at the indicated concentrations: chloramphenicol (Cm) 2.5 µg ml-1,
erythromycin at 5 µg ml-1, and tetracycline (Tc) at 5 µg ml-1 in LBS. E. coli strains were
cultured in Luria Bertani medium (LB) [43]. The following antibiotics were added to LB
medium at the indicated concentrations: Cm at 25 µg/ml-1, kanamycin (Kan) at 50 µg
ml-1, Tc at 15 µg/ml-1, or ampicillin (Ap) at 100 µg ml-1. For solid media, agar was
added to a final concentration of 1.5%.
Bioinformatics. Amino acid sequences for V. vulnificus RbdA, V. parahaemolyticus
SypAVP, and V. fischeri SypA were obtained from the National Center for Biotechnology
Information (NCBI) database. Alignments of RbdA, SypAVP, and SypA were generated
using the Clustal Omega multiple-sequence alignment program from EMBL-EBI
(http://ebi.ac.uk/Tools/msa/clustalo) [44].
Molecular and genetic techniques. The rbdA and sypAVP alleles used in this study were
generated by Polymerase Chain Reaction (PCR) using primers listed in Table 2. PCR
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products were cloned into the plasmid pARM47, a vector for chromosomal insertion at
the Tn7 site containing the lac promoter [45], that was digested to remove the sypE gene.
For dual promoter constructs, the homologous sypA genes were cloned downstream of
the V. fischeri sypA promoter. The Gibson Assembly kit (New England Biolabs) was
used to generate plasmid constructs for the homologous sypA genes. Alleles were inserted
into the chromosomal Tn7 site of V. fischeri strains using tetraparental conjugation. To
generate site-directed mutations in sypA, mutated alleles of sypA were generated by PCR
using mutagenic primers (Table 3) and the Gibson Assembly kit. The mutations were
confirmed by sequence analysis using ACGT, inc (Wheeling, IL).
Wrinkled colony formation assay. To observe wrinkled colony formation, the indicated
V. fischeri strains were streaked onto LBS agar plates containing the necessary
antibiotics. Single colonies were then cultured with shaking in LBS broth containing
antibiotics overnight at either 24°C (for rscS overexpressing strains) or 28°C (for sypG
overexpressing strains). The strains were then sub-cultured the following day in 5 ml of
fresh medium. Following growth to early log phase, the cultures were back-diluted in
LBS to an OD600 of 0.2. 10 µl of diluted cultures were spotted onto LBS agar plates,
containing necessary antibiotics, and grown at either ~ 24°C (for rscS overexpressing
strains) or 28°C (for sypG overexpressing strains). Images of the spotted cultures were
acquired over the course of the developmental process of biofilm formation at the
indicated time points using a Zeiss stemi 2000-C dissecting microscope.
Western blot analysis of V. fischeri lysates. V. fischeri strains were cultured in LBS
containing the appropriate antibiotics overnight at 24 °C. Cultures were standardized to
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the same amounts using OD600 measurements, concentrated by centrifugation, and lysed
in 500 µL 2X sample (4% SDS, 40 mM Tris pH 6.3, 10% glycerol) buffer. Samples were
resolved on either 10 or 15% SDS-PAGE gels (10% 29:1 acrylamide: N, N’-methylenebis-acrylamide, 375 mM Tris pH 8.6, 0.1% SDS), and transferred to PVDF membranes.
SypA and SypA-like proteins were detected by western blot analysis using rabbit anti-HA
antibody (Sigma-Aldrich, St. Louis, MO) followed by a secondary, donkey anti-rabbit
IgG antibody (Sigma-Aldrich, St. Louis, MO) conjugated to horseradish peroxidase
(HRP), and visualized using SuperSignal West Pico Chemiluminescent Substrate
(Thermo Fischer Scientific, Rockford, IL).
Assessment of SypA phosphorylation in vivo. Two plasmids were introduced into E.
coli, one that expressed either rbdA or sypAVP and one that expressed V. fischeri sypE and
the phosphorylation state of either the RbdA protein or the SypAVP protein was evaluated
using the Phos-tagTM reagent (Wako Chemicals USA, Inc., Richmond, VA). The PhostagTM reagent retards the migration of phosphorylated proteins. The reagent preferentially
binds to phosphorylated proteins, thus separating phosphorylated proteins from
unphosphorylated proteins and, resulting in a band shift observable following gel
electrophoresis and western blotting. E. coli strains were cultured overnight with shaking
in LB containing the appropriate antibiotics at 37°C. Cells were sub-cultured the
following day in 5 ml of fresh medium and grown for 8 hours. Aliquots of cells were
standardized to the same amounts using OD600 measurements, then concentrated by
centrifugation. Samples were lysed in 2X SDS sample buffer and resolved on SDSPAGE gels containing 25-30 µM Phos-tagTM acrylamide (WAKO Chemicals USA, Inc.,
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Richmond, VA) and 50-60 µM MnCl2. Gels were fixed for 15 min in standard transfer
buffer containing 1 mM EDTA, and then incubated an additional 20 min in transfer
buffer without EDTA. Proteins were transferred to a PVDF membrane and the proteins
were detected by western blot analysis using either an anti-HA or anti-FLAG antibody
(Sigma-Aldrich, St. Louis, MO).
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Table 1: Strains used in this study
Strains
Genotype
E. coli
GT115
V. fischeri
ES114
KV3299
KV4389
KV4390
KV4715
KV4716
KV5079
KV5479
KV6392
KV6393
KV6578
KV6579
KV6580
KV6581
KV6993

Reference
or source

F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1
endA1 Δdcm uidA(ΔMluI)::pir-116 ΔsbcC-sbcD

InvivoGen

WT

[40]
[26]
[46]
[46]
[32]
[32]
[32]
[32]
[32]
[32]
[47]
[47]
[47]
[47]
Sheila
McEwen
Sheila
McEwen
Sheila
McEwen
Sheila
McEwen
Sheila
McEwen
Sheila
McEwen
Sheila
McEwen
Sheila
McEwen
This Study
This Study

ΔsypE
attTn7::ermR
ΔsypE attTn7::ermR
ΔsypA
ΔsypA ΔsypE
ΔsypA attTn7::ermR
ΔsypA attTn7::sypA
ΔsypA ΔsypE attTn7::ermR
ΔsypA ΔsypE attTn7::sypA
ΔsypA attTn7::sypA-HA
ΔsypA attTn7::sypAS56A HA
ΔsypA ΔsypE attTn7::sypA-HA
ΔsypA ΔsypE attTn7::sypAS56A HA
ΔsypA ΔsypE attTn7::sypAK67A HA

KV6995

ΔsypA attTn7::sypAK67A HA

KV6998

ΔsypA ΔsypE attTn7::sypAQ84A HA

KV7000

ΔsypA attTn7::sypAQ84A HA

KV7003

ΔsypA ΔsypE attTn7::sypAR68A HA

KV7005

ΔsypA attTn7::sypAR68A HA

KV7008

ΔsypA ΔsypE attTn7::sypAR93A HA

KV7010

ΔsypA attTn7::sypAR93A HA

KV7169
KV7170

ΔsypA attTn7::rbdA plac only
ΔsypA attTn7::sypAVP plac only
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KV7172
KV7173
KV7309
KV7310
KV7313
KV7314
KV7315
KV7316
KV7325
KV7326
KV7327
KV7328
KV7558
KV7560
KV7562
KV7564
KV7566
KV7568
KV7570
KV7572
KV7559
KV7561
KV7563
KV7565
KV7567
KV7569
KV7571
KV7573

ΔsypA ΔsypE attTn7::rbdA plac only
ΔsypA ΔsypE attTn7::sypAVP plac only
ΔsypA attTn7::rbdA plac and psypA
ΔsypA ΔsypE attTn7::rbdA plac and psypA
ΔsypA attTn7::sypAVP plac and psypA
ΔsypA ΔsypE attTn7::sypAVP plac and psypA
ΔsypA attTn7::sypAVP-HA plac and psypA
ΔsypA ΔsypE attTn7::sypAVP-HA plac and psypA
ΔsypE attTn7::rbdA plac and psypA
attTn7::rbdA plac and psypA
ΔsypE attTn7::sypAVP plac and psypA
attTn7::sypAVP plac and psypA
ΔsypA attTn7::sypAE2A HA
ΔsypA attTn7::sypAG25A HA
ΔsypA attTn7::sypAD34A HA
ΔsypA attTn7::sypAY64A HA
ΔsypA attTn7::sypAE71A HA
ΔsypA attTn7::sypAR74A HA
ΔsypA attTn7::sypAG83A HA
ΔsypA attTn7::sypAP99A HA
ΔsypA ΔsypE attTn7::sypAE2A HA
ΔsypA ΔsypE attTn7::sypAG25A HA
ΔsypA ΔsypE attTn7::sypAD34A HA
ΔsypA ΔsypE attTn7::sypAY64A HA
ΔsypA ΔsypE attTn7::sypAE71A HA
ΔsypA ΔsypE attTn7::sypAR74A HA
ΔsypA ΔsypE attTn7::sypAG83A HA
ΔsypA ΔsypE attTn7::sypAP99A HA

This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
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Table 2: Plasmids used in this study
Plasmids
Description1
pARM7
pARM47
pARM163

pCLD56
pCMT12
pCMT14
pCMT16

rscS overexpression plasmid;
TetR
Derivative of Tn7 delivery
plasmid [45] pEVS107
that contains sypE, KanR, ErmR
Derivative of Tn7 delivery
plasmid pEVS107 [45] that
contains sypA-HA and its
promoter
Derivative of low copy vector
pKV282 that contains sypG
pARM47 containing rbdA (lac
promoter only)
pARM47 containing sypAVP (lac
promoter only)
pARM47 containing sypA (lac
promoter only)
pARM47 containing rbdA-HA

Reference
[46]
[46]
[47]

[47]
This study
This study
This study

pCMT19
This study
pARM47 containing sypAVP
pCMT21
This study
pARM47
containing
sypA
-HA
VP
pCMT22
This study
E2A
pARM47
containing
sypA
pCMT23
This study
G25A
pARM47
containing
sypA
pCMT24
This study
pARM47 containing sypAD34A
pCMT25
This study
Y64A
pARM47 containing sypA
pCMT26
This study
E71A
pARM47 containing sypA
pCMT27
This study
R74A
pARM47 containing sypA
pCMT28
This study
G83A
pARM47
containing
sypA
pCMT29
This study
P99A
pARM47
containing
sypA
pCMT30
This study
R
Low
copy
vector,
Tet
pKV282
[46]
1
All derivatives of pARM47 contain the indicated gene and lack the sypE gene; except
where indicated as “lac promoter only”, all pARM47 derivatives carry both the lac
promoter and the sypA promoter.
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Table 3: Oligonucleotides used in this study
Gene/Promoter
Sequence (5’ -3’)
sypA Gibson F
sypA Gibson R
VV sypA F
VV sypA-flag R
VP sypA F
VP sypA-flag R
VV sypA-HA R
VP sypA-HA R

GATTACGCCAAGCTTGCATGC
CAGTCTAGTTCTAGAGGGCCC
GATTACGCCAAGCTT GCATGCAACAGGAGAACGTCAC
CAGTCTAGTTCTAGAGGGCCCTTTATCATCATCATCTTT
ATAATCCTAAAACTGCTTGGAGTT
GATTACGCCAAGCTT GCATGCTAAATGGAGATAGGGT
C
CAGTCTAGTTCTAGA GGGCCCTTTATCATCATCATCTT
TATAATCTTAGTGTCCTTTTGAATTG
CAGTCTAGTTCTAGAGGGCCCTTATGCATAATCTGGAA
CATCATATGGATAAAACTGCTTGGAGTT
CAGTCTAGTTCTAGAGGGCCCTTATGCATAATCTGGAA
CATCATATGGATAGTGTCCTTTTGAATTG
GATTACGCCAAGCTTGCATGCTTCCCTAGGAGCTTATT
ATGG

sypA Gibson plac
only F
VV sypA Promoter R GTGACGTTCTCCTGTTGCATGCGCTCCTAGGGAATAAT
VP sypA Promoter R
sypA E2A F
sypA E2A R
sypA G25A F
sypA G25A R
sypA D34A F
sypA D34A R
sypA Y64A F
sypA Y64A R
sypA E71A F
sypA E71A R
sypA R74A F
sypA R74A R
sypA G83A F
sypA G83A R
sypA P99A F
sypA P99A R

CC
GACCCTATCTCCATTTAGCATGCGCTCCTAGGGAATAA
TCC
GCTTATTATGGCACTACATCAATTCGAATCAAATGA
ATTGATGTAGTGCCATAATAAGCTCCTAGGGAATA
GGACGCCATCGCATGTAGAGATATTCAACCATCCA
TATCTCTACATGCGATGGCGTCCATATCACCTT
ACCATCCATCGCAAGCGTGATTGAACAAGAACATC
CAATCACGCTTGCGATGGATGGTTGAATATCTCTA
CGCTATTGTTGCACTATATAAACGACTTATAGAGAAA
GTTTATATAGTGCAACAATAGCGCCAATACCTGA
ACGACTTATAGCAAAAGATCGTACTATGCAGATTAA
TACGATCTTTTGCTATAAGTCGTTTATATAGATAAACA
AGAGAAAGATGCAACTATGCAGATTAAAAATGCACA
TCTGCATAGTTGCATCTTTCTCTATAAGTCGTTTATA
AAATGCACATGCACAGCCACTAGAGTTACTAAAAC
CTAGTGGCTGTGCATGTGCATTTTTAATCTGCATAG
AAACGCAATTGCAGTTAATAAAACAACGCATTATCC
TTTTATTAACTGCAATTGCGTTTTCAATACGTAGAA

Primer
1727
1728
1745
1746
1747
1748
1817
1818
1820
1834
1835
1863
1864
1865
1866
1867
1868
1869
1870
1871
1872
1873
1874
1875
1876
1877
1878

CHAPTER THREE
EXPERIMENTAL RESULTS

Ability of the sypA-like genes from Vibrio pathogens to promote biofilm
formation by V. fischeri
Introduction
V. vulnificus and V. parahaemolyticus are two human pathogens that can cause
serious infections in humans and can have particularly high mortality rates in the case of
V. vulnificus. Several factors have been hypothesized to contribute to pathogenicity in
both organisms, although the cause for the high mortality rates remains unclear. One
hypothesis is that both bacteria can form a biofilm that in the human host can lead to
persistent infection.
The V. vulnificus genome includes a polysaccharide locus, rbd, that has been
previously shown to be involved in aggregation, although individual genes of the locus
have not been well characterized [4]. The rbd locus is conserved in the pathogen V.
parahaemolyticus and in the non-pathogen V. fischeri, where it has been extensively
characterized. In V. fischeri, this polysaccharide locus, called syp, is important in biofilm
formation. The deletion of genes within the syp locus results in strains that no longer
form a biofilm. Specifically, these strains do not produce wrinkled colonies, one readout
of biofilm formation.
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One of the regulators of biofilm formation in V. fischeri is SypA, a homolog of
both RbdA, encoded by the first gene in the V. vulnificus rbd locus, and SypAVP, encoded
by the first gene in the V. parahaemolyticus locus. The V. vulnificus RbdA protein has
55% identity and 73% similarity to V. fischeri SypA (E value=4e-39) [48], which is
required for syp-dependent biofilm formation in V. fischeri. The V. parahaemolyticus
SypA-like protein has 58% identity and 73% similarity to V. fischeri SypA (E value=e43) [48] (Figure 3). When sypA is deleted in V. fischeri, biofilms do not form. The
activity of SypA is negatively regulated via phosphorylation by SypE: when V. fischeri
SypA is phosphorylated, no biofilm forms.
The experimental goal is to elucidate the function of V. vulnificus RbdA and V.
parahaemolyticus SypAVP. Because of the high degree of conservation between RbdA,
SypAVP, and SypA and the tractability of the V. fischeri genome, this model of biofilm
formation can be used to further our understanding of the function of rbd-encoded
proteins and those encoded by V. parahaemolyticus. It is my hypothesis that because of
the substantial sequence similarity, these proteins, RbdA and SypAVP, and SypA are
orthologs. If the ability to promote biofilm formation is conserved in rbdA from V.
vulnificus, and sypAVP from V. parahaemolyticus, then V. fischeri biofilm-deficient sypA
mutant strains will form biofilms (wrinkled colonies) when the non-native genes are
expressed. These experiments will give insight into the function of the SypA-like proteins
in their own species and the role of STAS domain proteins in biofilm formation.
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Figure 3. Alignment of SypA-like proteins. To determine the similarity between RbdA,
SypAVP, and SypA, I aligned the three proteins [44]. The amino acid sequence is highly
conserved around serine 56 which in V. fischeri SypA is phosphorylated by SypE,
another protein encoded in the syp locus.
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Ability of V. vulnificus rbdA and V. parahaemolyticus sypAVP to promote biofilm
formation
To being to determine the function of rbdA and sypAVP in biofilm formation in
their own species, I assessed the ability of the two genes to promote biofilm formation by
V. fischeri. I separately introduced a copy of the rbdA gene and the sypAVP gene at the
Tn7 site in the chromosome of a V. fischeri strain deleted for sypA. I then induced strains
to form a biofilm and assessed wrinkled colony formation. In these experiments,
expression of rbdA and sypAVP was driven from the lac promoter alone. These constructs
did not induce production of wrinkled colonies (Figure 4). I hypothesized that the lack of
complementation may be due to insufficient levels of either RbdA or SypAVP.
In biofilm formation assays, a ΔsypA V. fischeri strain that was complemented
with sypA at the Tn7 site of the chromosome was used as a positive control for
complementation. The sypA complemented strain produced wrinkled colonies; however,
the sypA gene was expressed from two promoters, the lac promoter and the native sypA
promoter. I therefore hypothesized that the lac promoter alone was insufficient to induce
levels of SypA necessary for complementation. In support of this idea, when I expressed
the native V. fischeri sypA from the lac promoter alone, I similarly did not observe
wrinkled colony formation (Figure 5).
Therefore, I engineered constructs in which the rbdA gene and the sypAVP gene
were driven from the lac and sypA promoters, and I found that the complemented strains
were able to form wrinkled colonies (Figure 6). The wrinkling appeared similar to a
control strain that expressed the native V. fischeri sypA from the Tn7 site. However,

36

strains expressing sypAVP exhibited a slight delay in wrinkling. The SypAVP protein may
function less efficiently due to changes in amino acids that in the native SypA are
important for function.
The data from the biofilm assay suggested that a threshold of SypA is required for
biofilm formation. Western blotting was performed to compare SypAVP protein levels
and native V. fischeri SypA levels (Figure 7). V. fischeri SypA appears to be produced
more abundantly than SypAVP. Three microliters of extract containing SypA was loaded
on the gel while six microliters of extract containing SypAVP was loaded on the gel.
Interestingly, there was a difference in the migration of the V. fischeri and V.
parahaemolyticus proteins, a finding that will be discussed in the Discussion section.
Additionally, SypA protein was not visualized by Western blotting when expression of
the sypA gene was driven by the lac promoter alone, a result that likely accounts for its
inability to complement.
In the laboratory, biofilm induction is usually induced in two ways: overexpression of the response regulator, sypG or over-expression of the sensor kinase, rscS.
In the above biofilm assays, I induced strains to form a biofilm by overexpressing sypG.
In these strains, SypE, the negative regulator of SypA is absent. I also induced biofilm
formation by overexpressing the sensor kinase rscS. In these strains, SypE is absent, and
the sypA genes were expressed from the lac and sypA promoters. These strains, when
induced to form a biofilm, did not form the robust wrinkled colonies that I previously
observed using overexpression of sypG. The strains produced smooth colonies (Figure 8).
Strains expressing sypAVP began to wrinkle, but even after prolonged incubation, these
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strains did not appear similar to a positive control strain expressing V. fischeri sypA.
These results suggest that over-expression of the sensor kinase rscS might not lead to
sufficient production of SypA to produce wrinkled colonies.
Although the exact function of SypA is unknown, it is likely that SypA interacts
with other proteins to promote biofilm formation, potentially forming a complex with
itself and/or other proteins. In strains that express RbdA or SypAVP, this hypothetical
protein complex may not form correctly and/or may not work as efficiently as SypAexpressing cells to promote biofilm formation. To test the hypothesis that the presence of
RbdA or SypAVP may disrupt the interaction between SypA and itself or between SypA
and other proteins in promoting biofilm formation, I moved either rbdA or sypAVP into a
strain containing the native V. fischeri sypA. In these experiments, strains not expressing
rbdA or sypAVP wrinkle due to the presence of V. fischeri sypA. I expected that a strain
that expressed sypA and rbdA or sypA and sypAVP would produce smooth colonies if the
homologous proteins impaired the function of SypA. However, I found that rbdA and
sypA expressing strains produced wrinkled colonies (Figure 9). Wrinkling appeared
similar to strains expressing two alleles of V. fischeri sypA. Additionally, there was no
difference in the timing of wrinkling. These data suggest that if SypA is interacting with
itself or other proteins to promote biofilm formation, RbdA and SypAVP do not disrupt
this interaction. This level of regulation could help to ensure biofilm formation occurs at
the proper place and time in the environment.
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Figure 4. Neither rbdA nor sypAVP, when expressed from a single promoter,
promotes biofilm formation. A wrinkled colony assay was performed with strains
deficient for sypA and sypE and expressing rbdA and sypAVP from the chromosome. Gene
expression was driven by the lac promoter. Biofilm induction was achieved by overexpressing the gene for the response regulator, sypG. Pictures were taken at the indicated
time points.
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Figure 5. Biofilm production depends on sypA expression from two promoters. A
wrinkled colony assay was performed with strains deficient for sypA and sypE expressing
sypA from either the lac promoter alone or the lac and sypA promoters. Biofilm induction
was achieved by over-expressing the gene for the response regulator, sypG. Pictures were
taken at the indicated time points.
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Figure 6. rbdA and sypAVP expressed from two promoters promote biofilm
formation. A wrinkled colony assay was performed with strains deficient for sypA and
sypE and expressing either rbdA or sypAVP from the chromosome. Gene expression was
driven by the lac and sypA promoters. Biofilm induction was achieved by overexpressing the gene for the response regulator, sypG. Pictures were taken at the indicated
time points.
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Figure 7. SypA migrates to a higher molecular weight than SypAVP. Whole cell
lysates were electrophoresed on an SDS-PAGE gel. Proteins were visualized using rabbit
anti-HA primary antibody and a donkey anti-rabbit IgG HRP-conjugated secondary
antibody. The first lane contains an extract from V. fischeri ΔsypA expressing SypA-HA
(3 µl loaded). The second lane contains an extract from V. fischeri ΔsypA expressing
untagged SypA (3 µl loaded). The third lane contains an extract from V. fischeri ΔsypA
expressing V. parahaemolyticus SypAVP-HA (6 µl loaded).
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Figure 8. Biofilm induction by RscS does not promote biofilm formation of strains
expressing rbdA or sypAVP. A wrinkled colony assay was performed with strains
deficient for sypA and sypE and expressing rbdA or sypAVP from the chromosome. Gene
expression was driven by the lac and sypA promoters. Biofilm induction was achieved by
over-expressing the gene for the sensor kinase, rscS. Pictures were taken at 41, 51, and 66
hours.
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Figure 9. Co-expression of rbdA or sypAVP with sypA does not impact biofilm
formation. A wrinkled colony assay was performed with strains deficient for sypE and
expressing rbdA and sypA or sypAVP and sypA. Gene expression of rbdA and sypAVP was
driven by the lac and sypA promoters. Biofilm induction was achieved by overexpressing the gene for the response regulator, sypG. Pictures were taken at the indicated
time points.
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Summary
The goal of this study was to elucidate the function of V. vulnificus RbdA and V.
parahaemolyticus SypAVP. I hypothesized that because of the substantial sequence
similarity, these proteins, RbdA and SypAVP, and SypA are orthologs. If the ability to
promote biofilm formation is conserved in rbdA from V. vulnificus, and sypAVP from V.
parahaemolyticus, then V. fischeri biofilm-deficient sypA mutant strains will form
biofilms (wrinkled colonies) when the non-native genes are expressed. I determined that
rbdA and sypAVP have the ability to promote biofilm formation in V. fischeri as both
genes were able to functionally complement a sypA-deficient V. fischeri strain for biofilm
formation. These results suggest that RbdA and SypAVP may play a similar role in
promoting biofilm formation in their own species. Complementation appears to depend
on the presence of a minimal level of protein as expression of genes driven from the lac
promoter alone was not enough to produce wrinkled colonies. Strains only produced
wrinkled colonies when gene expression was driven from the lac and syp promoters.
Wrinkled colonies were only observed when strains were induced to form a biofilm by
overexpression of sypG. Cells overexpressing rscS did not produce the same wrinkled
colonies. These experiments indicate there may be differences between SypA proteins,
and provide insights into SypA function. Overall, these results validate this approach as
one that can provide insights into the function of homologous genes from related species.
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Ability of the SypA-like proteins from Vibrio pathogens to serve as a
substrate for phosphorylation by V. fischeri SypE
Introduction
It has previously been shown that SypA is regulated by phosphorylation at a
specific serine residue by another protein encoded within the syp locus, SypE [32]. When
active, SypE phosphorylates SypA, inactivating it and inhibiting biofilm formation.
When SypE is inactive, SypA is unphosphorylated and can promote biofilm formation.
Like SypA, RbdA and SypAVP each contain a serine residue, predicted to be the site of
phosphorylation, that is highly conserved in STAS domain proteins. Not only is the
serine conserved, but many surrounding amino acid residues are conserved between the
three proteins. Thus, it is possible that RbdA and SypAVP are also phosphorylated.
Furthermore, it is plausible that SypE can recognize and phosphorylate RbdA and
SypAVP due to the high conservation not only of the serine but also the surrounding
amino acids. However, neither V. vulnificus nor V. parahaemolyticus have a SypE
homolog, suggesting that the ability to be phosphorylated may not be conserved.
Alternatively, it is possible that another serine kinase, distinct from SypE, could
phosphorylate these proteins. Given the serine conservation as well as the sequence
conservation between SypA, RbdA, and SypAVP, I hypothesize that the SypA-like
proteins can be phosphorylated by SypE; if so, they may also be regulated by
phosphorylation in their native organism. The studies in this section are designed to test
this hypothesis.
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Ability of V. vulnificus RbdA and V. parahaemolyticus SypAVP to be controlled by
SypE
My previous biofilm studies made use of strains in which the biofilm inhibitor
SypE, which phosphorylates and thus inactivates SypA, was missing or inactivated. Here,
I assessed the ability of SypE to control the activity of RbdA and SypAVP using a genetic
approach. I assessed biofilm formation in a sypA-deficient strain expressing not only
rbdA or sypAVP but also sypE. If SypE can recognize and phosphorylate these SypA
homologs, smooth colonies will be produced. Alternatively, if the SypA homologs cannot
be controlled by SypE, wrinkled colonies will be produced even in the presence of the
biofilm inhibitor.
As previously observed, strains expressing V. fischeri sypA and its negative
regulator sypE produce smooth colonies when induced to form a biofilm (Figure 10). In
contrast, a control strain expressing sypE and a mutant V. fischeri sypA allele that cannot
be phosphorylated produced wrinkled colonies when induced to form a biofilm. When
either rbdA or sypAVP was co-expressed with sypE in a strain deficient for sypA, smooth
colonies were produced (Figure 10). At later time points, strains co-expressing rbdA and
sypE exhibited a partial wrinkling phenotype. These data suggest RbdA is inactivated by
SypE but inactivation may be inefficient or overcome with time.
Data suggesting that RbdA is controlled by SypE led to the hypothesis that RbdA
could serve as the preferred target for SypE’s inhibitory activity, thus sequestering SypE
and freeing SypA to promote biofilm formation. To test if RbdA or SypAVP could be
preferentially inhibited by SypE, allowing SypA to promote biofilm formation, I
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expressed sypA, and sypE, along with either rbdA or sypAVP, in V. fischeri and induced
biofilm formation using SypG (Figure 11). Strains expressing rbdA or sypAVP with sypA
and sypE did not wrinkle, suggesting that the non-native proteins do not interact more
strongly with SypE than SypA and that both proteins are likely inactivated by
phosphorylation.
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Figure 10. Function of RbdA and SypAVP is controlled by SypE. A wrinkled colony
assay was performed with strains deficient for sypA and expressing sypE and rbdA or
sypAVP. Gene expression of rbdA and sypAVP was driven by the lac and sypA promoters.
Biofilm induction was achieved by over-expressing the gene for the response regulator,
sypG. Pictures were taken at the indicated time points.
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Figure 11. Co-expression of rbdA or sypAVP with sypA in the presence of sypE does
not promote biofilm formation. A wrinkled colony assay was performed with strains
expressing sypE and rbdA and sypA or sypAVP and sypA. Gene expression of rbdA and
sypAVP was driven by the lac and sypA promoters. Biofilm induction was achieved by
over-expressing the gene for the response regulator, sypG. Pictures were taken at 25, 50,
and 67 hours.
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Genetic studies suggested that SypE controls RbdA. To test if this control is due
to phosphorylation of RbdA, as is the case with V. fischeri SypA, I tried to visualize the
RbdA by phos-tag gels and Western blotting. The phos-tag reagent retards the migration
of phosphorylated proteins by preferentially binding to phosphorylated proteins, thus
separating phosphorylated proteins from unphosphorylated proteins, resulting in a band
shift observable following gel electrophoresis and western blotting. However, I have been
unable to visualize bands correlating to RbdA and SypA in the presence of a vector or
SypE in E. coli when visualizing protein by phos-tag. Furthermore, when I have observed
the proteins, no shift was evident, even with my native SypA-HA control. SypA has
previously been shown to be phosphorylated via phos-tag when SypA was GST-tagged
[32]. If a shift can be visualized between the GST-tagged SypA in the presence of vector
vs. SypE but not with untagged SypA, then it is likely that SypA, and therefore SypAVP
and RbdA, will need to be GST-tagged to observe the phosphorylated state. If I obtain
this result, future directions beyond the scope of my thesis would be to generate larger
fusion protein with RbdA and SypAVP and then assess their phosphorylation state.
Given the sequence similarities—V. parahaemolyticus SypAVP also has a
conserved serine that could be phosphorylated—I hypothesized that this protein may also
be recognized and phosphorylated by SypE. Either phosphorylation or physical
interaction between SypE and SypAVP could account for the ability of SypE to inhibit
SypAVP-induced biofilm formation. To test if SypAVP is inhibited by phosphorylation by
SypE, I visualized SypAVP by phos-tag. Preliminary data has shown the SypAVP may be
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phosphorylated. It is difficult to tell, however, since the positive control for band shift,
phosphorylated SypA, was not be visualized by Western blot.
Summary
Given their sequence similarity and their ability to complement a sypA mutant, I
hypothesized that RbdA and SypAVP are true orthologs of SypA. If so, then they should
be susceptible to control by SypE. I hypothesized that when sypE is expressed in strains
complemented with either rbdA or sypAVP, the strains will no longer produce wrinkled
colonies. I found this to be true; strains expressing either rbdA or sypAVP failed to form a
biofilm in the presence of SypE. This result is the same as when sypE is expressed with
the native sypA, because SypA becomes phosphorylated and thus inactivated. These
results suggest that SypE is able to control the functions of RbdA or SypAVP potentially
by phosphorylation. It is interesting that V. vulnificus and V. parahaemolyticus do not
have SypE homologs, but are still sensitive to SypE. It is formally possible that SypE
does not phosphorylate RbdA or SypAVP, but rather binds to these proteins, physically
preventing them from interacting with other proteins to promote biofilm formation.
Future work is necessary to distinguish amongst these possibilities.
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Identify specific residues important for biofilm formation and for
recognition and phosphorylation by SypE
Introduction
Both rbdA and sypAVP were able to promote biofilm formation in a strain in which
the native sypA was absent, suggesting that amino acids important for interaction with
SypA’s partner in promoting biofilm formation are conserved in all three species. In
addition, RbdA and SypAVP also appeared to be susceptible to regulatory control by
SypE. Thus, amino acids important for (1) biofilm formation and (2) interaction with
SypE must be conserved in all three species. Mutating amino acids in SypA important for
interaction with a putative downstream partner would disrupt biofilm formation, while
mutations that impact its interaction with SypE could result in a protein that is blind to
SypE’s inhibitory effects. Mutagenesis of SypA could result in null mutants. These
mutants could provide insight into amino acids that are required for the stability of the
protein.
Identification and mutation of conserved amino acids
To determine the similarity between the proteins, I first compared the amino acid
sequence of V. vulnificus RbdA, V. parahaemolyticus SypAVP, and V. fischeri SypA and
identified amino acids conserved in all three proteins (Figure 12) [44]. I then compared
the conserved amino acids in the SypA-like proteins to other STAS domain proteins and
chose to mutate amino acids that were not conserved in other STAS domain proteins
(Data not shown). The amino acids that are conserved in Vibrio species, but not in other
unrelated STAS domain proteins, could be critical for RbdA’s function in promoting
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biofilm formation and/or in interacting with SypE. I generated point mutations in codons
for conserved amino acids that I hypothesized to be important for biofilm formation in an
allele of sypA and introduced copies of the genes into the Tn7 site in the V. fischeri
chromosome to assess biofilm formation and interaction with SypE.
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Figure 12. SypA point mutations. In red are mutations that I have made. In blue are
mutations previously made in the lab. Above the amino acid sequence is the secondary
structure of the SypA protein as predicted by threading the protein onto another known
STAS domain protein [44].
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Investigation into the roles of conserved amino acids in promoting biofilm formation
I generated eight sypA alleles with a single point mutation. I chose to mutate
residues to alanine as alanine is non-bulky and least affects protein secondary structure.
The mutations were confirmed by sequence analysis using ACGT, inc (Wheeling, IL). I
then performed a sensitive time course assay and found six amino acids that are important
for promoting biofilm formation. Interestingly, some amino acids appeared to be more
important than others as there were a range of defects (Figure 13). Some mutants were
delayed for biofilm formation while others failed to form a biofilm altogether. Strains that
expressed SypA with either of two amino acid mutations, E2A and Y64A, were delayed
and defective for biofilm formation. Even after days of growth, these mutants never
formed wrinkled colonies similar to the positive control. Yet another strain, expressing
SypA-D34A, was completely defective for biofilm formation, never producing wrinkled
colonies. Strains expressing SypA-R74A or SypA-G83A, had short delays in biofilm
formation, but produced normal wrinkled colonies at later time points. The SypA-E71Aexpressing strain produced wrinkled colonies with a normal timing and pattern, but the
colonies attached poorly to the plate, indicating some defect in biofilm development.
Finally, strains expressing either SypA-G25A or SypA-P99A did not exhibit any defect,
suggesting that those amino acids are not required for biofilm formation under these
conditions.
In addition to the eight mutations I made, four other mutations have been made in
SypA by a previous member of the lab. Three of the four mutations resulted in strains
that no longer produced wrinkled colonies. When assessed in conjunction with the
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mutants I have generated, we can determine what part(s) of the protein is important for
function in forming the biofilm. Using Cn3D [49], an application used to view the 3dimensial structures of proteins, I visualized the location of the mutations in SypA that
resulted in a biofilm-defective phenotype. Many of these mutations are located on the
same face of two alpha helices. This face of the protein may interact with another protein
to promote biofilm formation. I hypothesize that, when these amino acids are changed,
SypA can no longer interact with its putative partner.
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Figure 13. SypA point mutants have a range of effects on biofilm formation. A
wrinkled colony assay was performed with strains deficient for sypA and sypE and
expressing the mutant sypA. Biofilm induction was achieved by over-expressing the gene
for the response regulator, sypG. Pictures were taken at the indicated time.
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Investigation into the roles of conserved amino acids in recognition and
phosphorylation by SypE
The activity of SypA is negatively controlled via phosphorylation by SypE. To
date, Serine 56 is the only residue known to be critical for the ability of SypE to
recognize and control SypA’s activity. I predicted that other residues are also important
for the interaction between SypA and SypE. I anticipated that mutations that change
amino acids in SypA important for recognition by SypE will result in a SypA protein no
longer recognized and/or phosphorylated by SypE. When introduced into a strain that
expresses SypE, a mutant SypA that fails to interact with SypE will overcome its
inhibition activity, permitting biofilm formation under conditions in which it typically
does not occur.
I expect SypA mutants with changes in amino acids that are important for
recognition and phosphorylation by SypE will promote the formation of wrinkled
colonies even when the genetic background results in the production of inhibitory SypE.
However, thus far strains expressing SypA with any of the eight mutations I have
generated have produced smooth colonies in the presence of SypE, suggesting these
mutant SypA proteins are still susceptible to control by SypE (Figure 14).
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Figure 14. SypA point mutations are susceptible to control by SypE. A wrinkled colony
assay was performed with strains deficient for sypA and expressing the mutant sypA as well
as sypE. Biofilm induction was achieved by over-expressing the gene for the response
regulator, sypG. Pictures were taken at 24 and 48 hours.
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Summary
I hypothesized that amino acids important for biofilm formation must be
conserved in the three homologous STAS domain proteins, RbdA, SypAVP, and SypA as
all three proteins are able to promote biofilm formation. I identified conserved resides
and generated mutations in which these resides were changed to alanine. When assessed
for biofilm formation in a V. fischeri ΔsypA strain, some mutations result in delayed and
defective wrinkled colonies. Other mutations only resulted in delayed wrinkled colony
formation. Changes in SypA residues important for interaction with other proteins may
prevent interactions from occurring thereby by inhibiting biofilm formation. The amino
acids mutations I have made thus far do not have any effects on the ability of SypE to
recognize and phosphorylate SypA. These mutants can be used in further studies to
elucidate the function of SypA and identify other proteins SypA may interact with to
promote biofilm formation.

CHAPTER FOUR
DISCUSSION

In this thesis, I investigated the function of the SypA-like proteins encoded by the
pathogenic Vibrio species V. vulnificus and V. parahaemolyticus using the nonpathogenic relative, V. fischeri. The V. fischeri model of biofilm formation utilizes a
readily visualized phenotype, wrinkled colonies, to determine the contribution of specific
genes to biofilm formation. When genes important for biofilm formation such as sypA are
deleted, strains produce smooth colonies. Genes, such as rbdA or sypAVP, can easily be
moved into the chromosome to assess their ability to promote biofilm formation. This
work has revealed that RbdA and SypAVP function similarly to V. fischeri SypA in
promoting biofilm formation, producing wrinkled colonies. The ability to promote
biofilm formation and produce wrinkled colonies must be conserved in the proteins of all
three organisms. In the course of this work, I also obtained unexpected findings that have
permitted a greater understanding of the role of the STAS domain protein, SypA, in
biofilm formation.
Single promoter vs. dual promoter expression of SypA
My work revealed that expression of V. fischeri sypA (and, similarly, of rbdA or
sypAVP) from the lac promoter alone was insufficient to promote biofilm formation. This
was somewhat surprising, as the lac promoter (alone) has been sufficient to promote gene
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expression of other genes in previous complementation studies, resulting in biofilm
formation [50]. In contrast, when sypA was expressed from the lac promoter as well as
the sypA promoter, strains produced wrinkled colonies; whether both promoters are
required for optimal expression of the non-native syp genes, or merely the native V.
fischeri sypA promoter is yet unknown.
There are several possibilities that may account for the results I observed. sypA
expression from the lac promoter alone may not complement a V. fischeri sypA deletion
strain because there may not be sufficient levels of sypA transcript present needed to
produce high levels of protein. In support of this possibility, I was unable to detect SypA
protein from V. fischeri expressing native sypA from the lac promoter alone via Western
blot. However, these data don’t exclude alternative possibilities. For example, the lac
promoter may produce sufficient levels of sypA messenger RNA, but the sypA messenger
RNA transcripts may be unstable and degraded before the transcript can be translated into
SypA protein. Such instability could be due to the presence, in the lac-driven sypA
transcript, of a sequence that signals degradation of the transcript or that forms a
secondary structure, such as a stem loop, that prevents translation. Another possibility is
that there’s temporal control over the lac promoter: it is presumed to be constitutively
active, producing sypA transcripts and thus SypA protein during log and lag phase, but
perhaps it doesn’t function well during stationary phase, the phase during which biofilm
formation occurs. It remains to be determined which of these various possibilities
accounts for the failure of the lac promoter-driven rbdA and sypAVP to complement the
sypA mutant.

63

Aberrant migration of V. fischeri SypA
I found that the migration of the SypA-HA in a SDS gel differed from that of
SypAVP-HA, with SypAVP migrating to the position expected for both proteins. For SDSPAGE and Western blot preparation, SypA samples are lysed in 2X sample buffer
containing sodium dodecyl sulfate (SDS) and β-mercaptoethanol and boiled, after which
samples are run on SDS gels. SDS denatures proteins by disrupting non-covalent bonds
causing proteins to lose their native conformation. β-mercaptoethanol is a reducing agent
that has the ability to disrupt the structure of proteins by breaking disulfide bonds
between proteins. Thus, the altered migration of SypA may not be due to a non-covalent
interaction, or else not due to a protein-protein interaction.
Based upon the observation that SypA protein migrates to a higher molecular
weight than predicted, I speculate that SypA may be forming a covalently bonded
complex with itself, or potentially be modified by another molecule such as a lipid or
polysaccharide. Various treatments can be applied to the cells, prior to evaluating the
migration of SypA, to determine the nature/stability of a putative interaction or
modification. This could provide insight into what SypA is interacting with and how it is
functioning to promote biofilm formation. This interaction may not be important for
biofilm formation, however, as SypAVP migrates as predicted for its molecular weight yet
still promotes biofilm formation. Thus, this analysis could identify a previously unknown
function of SypA.
SypA interaction with other molecules
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Previous studies have determined that SypA is unlikely to act as an anti-sigma
factor antagonist (Sheila McEwen and Karen Visick, personal communication), and thus
how SypA functions remains unclear. Because there appears to be a minimum amount of
SypA required to promote biofilm formation, I speculate that SypA is a structural protein,
rather than a regulator. Potentially, SypA could interact with other proteins within a
stressosome complex, like RsbR and RsbS [35]. Identifying the other protein(s) with
which SypA interacts is an important step in understanding SypA function. I anticipate
that, if SypA functions within a stressosome, or as part of another complex, the same will
be true for RbdA and SypaVP since these non-native proteins can promote biofilm
formation in V. fischeri.
One method that can be used to elucidate SypA’s binding partner is a Far-Western
[51]. In this method, SypA would be used as a non-antibody probe to identify proteinprotein interactions in a cell lysate. V. fischeri cell lysate is electrophoresed on a native
gel. Purified, epitope-labelled SypA that can be detected using an antibody is used to
probe and detect a target on the membrane. The resulting band on the gel observed after
probing corresponds to the protein interacting with SypA. Alternatively, specific
candidate partners can be tested more directly using co-immunoprecipitation. When sypA
is not active, there is no polysaccharide production (Visick, personal communication),
suggesting SypA interacts with other proteins within the Syp pathway. Thus, coimmunoprecipitation assays with epitope-tagged Syp proteins can be performed to
determine direct interactions between SypA and other Syp proteins.
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In addition to interacting with a partner to facilitate biofilm formation, it is
possible that SypA may also bind GTP and/or may have GTPase activity. STAS domain
proteins from other bacterial species have been shown to bind and hydrolyze GTP in
addition to performing other functions. For example, the STAS domain protein Rv1739c
from M. tuberculosis has GTP binding and hydrolyzing capabilities [36]. The STAS
domain protein SpoIIAA of B. subtilis also has reported GTP binding and hydrolyzing
activity, although the consequence of this activity has yet to be determined [52].
Comparisons can be made between SypA and STAS domain proteins known to bind GTP
to determine if amino acids known to be shifted upon GTP binding are conserved in
SypA. If the ability to bind GTP is a common function of STAS proteins, then SypA
might behave similarly. If SypA binds GTP, then one of the mutants that I generated may
be defective for this activity. Future work can determine if SypA binds GTP and, if so,
whether that activity is important for biofilm formation and/or interactions with SypE.
Because of the conserved ability of RbdA and SypAVP to promote biofilm
formation, it is plausible that any additional function of V. fischeri SypA is also
conserved. If V. fischeri has GTP binding or GTPase activity, then it is possible that these
functions are conserved in the proteins of other species and that RbdA and SypAVP could
be have GTP binding or GTPase activity. Further studies could determine the impact(s)
of these additional functions have on biofilm formation and the pathogenesis of either V.
vulnificus and V. parahaemolyticus.
SypA point mutants
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I have identified conserved amino acids that are important for the ability of SypA
to promote biofilm formation. I generated point mutations in codons for conserved amino
acids that I hypothesized to be important for biofilm formation, and found that a subset of
these mutations did, in fact, disrupt biofilm formation in complementation experiments.
In complementation experiments, SypA point mutations had a range of effects on
biofilm formation. While some mutations resulted in proteins with diminished function,
others could no longer promote biofilm formation. These loss of function alleles may not
promote biofilm formation for several reasons. One reason for the lack of biofilm
formation may be that the mutant SypA protein may not be produced. The SypA mutants
I generated are epitope tagged, and thus Western blotting can be performed to determine
if the protein is made.
One approach that may provide some insight into whether SypA is folded is
evaluating the ability of SypE to phosphorylate SypA; if the mutant SypA is able to be
phosphorylated by SypE, it would suggest the protein is adequately folded to permit
SypE to recognize and phosphorylate SypA. If the mutant SypA cannot be
phosphorylated, it may be due to improper SypA folding.
The positions of amino acids that are required for biofilm formation can be
analyzed using Cn3D [49], an application used to view the 3-dimensial structures of
proteins. When I visualized the location of the mutations in SypA that resulted in a
biofilm-defective phenotype, I found that three mutations, tyrosine 64, lysine 67, and
arginine 68, are located on the same face of one alpha helix. The amino acids on this face
of the protein may interact with another protein to promote biofilm formation. I
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hypothesize that, when these amino acids are changed, SypA can no longer interact with
its putative partner. Four additional amino acids are located on the same face of the alpha
helix as these required amino acids including glycine 60, leucine 65, leucine 69, and
isoleucine 70. These residues may provide points of contact between SypA and another
protein, and this interaction may promote biofilm formation. Substitution of these
residues with alanine may prevent contact between SypA and its partner, this inhibiting
biofilm formation.
In addition to loss of function mutants, some mutations may result in proteins
with enhanced function. Strains expressing alleles that have enhanced function might
form biofilms at earlier time points than wild-type strains. Alternatively, point mutant
strains may form an enhanced biofilm due to increased adherence of the cells. This
phenotype has been observed previously in the lab (Ondrey and Visick, personal
communication): cells of control strain adhere to each other during biofilm formation, but
cells of strains that form enhanced biofilms adhere not only to each other but to the agar
plate as well. I observed that some of my strains that expressed a mutant allele of sypA
adhered to the plate, suggesting that changes in some amino acids may result in a SypA
protein with an enhanced ability to promote biofilm formation. However, whether this
altered adherence actually represents an enhanced or a defective biofilm has yet to be
determined.
Some mutants were more defective for biofilm formation than others. These SypA
mutants that produce smooth colonies when induced to form a biofilm can be used in
further studies to find suppressor mutants. These strains can be mutagenized by UV
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radiation, and mutagenized strains that are able to restore wrinkling contain either
revertant or suppressor mutations. The genome of these mutant strains that are able to
restore biofilm formation can be analyzed to determine the location of the mutation. If the
mutant is a suppressor mutant, it could give insight into what protein(s) SypA is
interacting with and how it is functioning.
Function and control of RbdA and SypAVP
In complementation experiments, rbdA and sypAVP were able to promote biofilm
formation. The ability to produce wrinkled colonies in V. fischeri suggests that both
RbdA and SypAVP are performing similar roles in promoting biofilm formation as V.
fischeri SypA. Thus, the function of this STAS domain protein has been conserved
among the species. RbdA and SypAVP may be functioning in a similar way to promote
biofilm formation in their own species. Furthermore, the V. fischeri model of biofilm
formation can be used to assess the function of genes from related species.
While rbdA and sypAVP were able to promote wrinkled colony formation in strains
induced by sypG, they did not do so in strains induced by rscS. The difference observed
under the two conditions may be due to the amount of transcript produced, as it is known
that sypG is a stronger inducer of biofilm formation. Alternatively, the difference may be
due to the position of the ribosomal binding site in the non-native sypA genes. The
plasmid constructs containing the non-native genes contain the ribosomal binding sites
for V. vulnificus and V. parahaemolyticus, which may not be optimal for V. fischeri.
Overexpression of sypG might induce enough transcription to overcome the effects of the
non-optimal ribosomal binding site, but overexpression of rscS, which does not induce
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syp transcription to the same extent as does sypG, may not be able to overcome this
potential decreased translation. Biofilms induced by rscS may not produce enough rbdA
or sypAVP to meet the minimum amount of protein required to promote biofilm formation.
Experiments are on-going to determine if this trivial explanation can account for the
dramatic differences in complementation depending whether sypG or rscS is
overexpressed. If it doesn’t, then I would conclude that the differences in
complementation are due to differences in functionality of the protein. The non-native
SypA produced may not function as well as the native SypA due to differences between
the proteins. The abundance of the sub-optimally functioning protein, which occurs
during sypG induction of biofilms, may be able to overcome deficits in biofilm
formation.
My work also showed that the ability of RbdA and SypAVP to be controlled by
SypE is conserved, although V. vulnificus and V. parahaemolyticus have lost the gene for
the SypE homolog. However, my current results do not demonstrate that SypE retains the
ability to phosphorylate these non-native proteins. An alternative hypothesis is that SypE
retains the ability to bind and thus sequester the SypA homologs, preventing their
biofilm-promoting activity. If SypE can phosphorylate these proteins, and
phosphorylation is indeed key to controlling their activity (as assessed with mutants with
changes at the conserved site of phosphorylation), then it is possible that, in V. vulnificus
and V. parahaemolyticus, another kinase may perform the function of SypE.
Significance
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My work demonstrates that the function of the SypA STAS domain protein is
conserved among three Vibrio species, V. vulnificus, V. parahaemolyticus, and V.
fischeri. While the precise function(s) of these STAS domain proteins remains unclear,
they all can function in promoting biofilm formation by V. fischeri. It is important to
understand the function of SypA as it plays a crucial role in biofilm formation. Because
rbdA and sypAVP can complement a V. fischeri mutant, it is likely that RbdA and SypAVP
are similarly required for biofilm formation in their own species, pathogenic bacteria
whose ability to cause disease may depend on biofilm formation.
Unlike the best-characterized bacterial STAS domain proteins (e.g., SpoIIAA and
RsbV [35]), SypA does not appear to function as an anti-sigma factor antagonist. Further
work elucidating the function of SypA will contribute to our understanding of the role of
STAS domain proteins in signaling and in other cell processes. My work has advanced
our understanding of SypA as we now know that SypA must be present at sufficient
levels to promote biofilm formation, suggesting it may have a structural rather than
regulatory role. Additionally, my evidence suggests that SypA may have unusual
properties and/or may be modified, as it runs aberrantly in an SDS gel.
Previous studies have shown that the rbd locus in V. vulnificus contributes to
aggregation [4], however, individual genes of the locus have not been studied. This locus
is conserved in V. parahaemolyticus, but no studies of its function have been reported.
Determining the contribution of individual genes in either locus to biofilm formation is
an important step in understanding how V. vulnificus and V. parahaemolyticus biofilms
form. We can use the V. fischeri model of biofilm formation to determine the function of
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genes from V. vulnificus and V. parahaemolyticus by complementing a mutant V. fischeri
strain. My work has shown that rbdA and sypAVP are able to complement a V. fischeri
mutant indicating a conservation in function between these proteins. It is likely that RbdA
and SypAVP are required for biofilm formation in their own species as well.
As potential regulators of biofilm formation, RbdA and SypAVP and the
complexes they may form could serve as a potential target for an inhibitor of biofilm
formation. An inhibitor of V. vulnificus or V. parahaemolyticus biofilms could serve
many purposes. While there exist many treatments options for removing bacteria from
the oyster population, few treatments effectively remove all the bacteria. Treatments that
are effective are costly. When treatments are not effective and bacteria persist in the
oyster population, increased human transmission and infection due to bacterial
contamination can occur. Outbreaks can lead to recall of oysters which can be financially
devastating to the oyster industry. An inhibitor of biofilm formation could be used as a
treatment to effectively remove bacteria from oyster populations harvested for human
consumption. This inhibitor could target a potential regulator of biofilm formation such
as RbdA in V. vulnificus or SypAVP in V. parahaemolyticus. Inhibitors of V. vulnificus or
V. parahaemolyticus biofilms could also be used to treat humans infected with either
organism. Drugs that prevent the formation of a V. vulnificus biofilm in a susceptible
individual could drastically improve patient outcome.
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